etoposide has been researched along with mln 8237 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, K; Blackhall, F; Dive, C; Forster, M; Foy, V; Frese, KK; Gomes, F; Lallo, A; Schenk, MW | 1 |
| Beijersbergen, RL; Bernards, R; De Conti, G; Groot, K; Jansen, R; Jin, H; Jochems, F; Leite de Oliveira, R; Pogacar, Z; Schepers, A; Thijssen, B; Wang, C; Wang, L; Wessels, LFA | 1 |
1 review(s) available for etoposide and mln 8237
| Article | Year |
|---|---|
Targeting DNA damage in SCLC.
Topics: Aurora Kinases; Azepines; Benzimidazoles; Carbolines; Cell Cycle Checkpoints; Cell Proliferation; Cytotoxins; DNA Damage; DNA Repair; Etoposide; Genomic Instability; Heterocyclic Compounds, 4 or More Rings; Humans; Lung Neoplasms; Molecular Targeted Therapy; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Protein Kinase Inhibitors; Pyrimidines; Rad51 Recombinase; Small Cell Lung Carcinoma | 2017 |
1 other study(ies) available for etoposide and mln 8237
| Article | Year |
|---|---|
The Cancer SENESCopedia: A delineation of cancer cell senescence.
Topics: Aniline Compounds; Azepines; Cell Line, Tumor; Cellular Senescence; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Pyrimidines; Reproducibility of Results; Senescence-Associated Secretory Phenotype; Senotherapeutics; Sulfonamides | 2021 |